WO2016105084A3 - 당뇨병 치료용 약제학적 조성물 - Google Patents
당뇨병 치료용 약제학적 조성물 Download PDFInfo
- Publication number
- WO2016105084A3 WO2016105084A3 PCT/KR2015/014096 KR2015014096W WO2016105084A3 WO 2016105084 A3 WO2016105084 A3 WO 2016105084A3 KR 2015014096 W KR2015014096 W KR 2015014096W WO 2016105084 A3 WO2016105084 A3 WO 2016105084A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pharmaceutical composition
- treating diabetes
- dpp
- inhibitor
- metformin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201580070627.7A CN107205969B (zh) | 2014-12-23 | 2015-12-22 | 糖尿病治疗用药物组合物 |
SG11201705194XA SG11201705194XA (en) | 2014-12-23 | 2015-12-22 | Pharmaceutical composition for treating diabetes |
MYPI2017702340A MY196438A (en) | 2014-12-23 | 2015-12-22 | Pharmaceutical Composition for Treating Diabetes |
PH12017501184A PH12017501184B1 (en) | 2014-12-23 | 2017-06-22 | Pharmaceutical composition for treating diabetes |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020140186677A KR101526825B1 (ko) | 2014-12-23 | 2014-12-23 | 당뇨병 치료용 약제학적 조성물 |
KR10-2014-0186677 | 2014-12-23 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2016105084A2 WO2016105084A2 (ko) | 2016-06-30 |
WO2016105084A3 true WO2016105084A3 (ko) | 2016-09-09 |
Family
ID=53500898
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2015/014096 WO2016105084A2 (ko) | 2014-12-23 | 2015-12-22 | 당뇨병 치료용 약제학적 조성물 |
Country Status (7)
Country | Link |
---|---|
KR (1) | KR101526825B1 (ko) |
CN (1) | CN107205969B (ko) |
MY (1) | MY196438A (ko) |
PH (1) | PH12017501184B1 (ko) |
SG (1) | SG11201705194XA (ko) |
TW (1) | TW201628602A (ko) |
WO (1) | WO2016105084A2 (ko) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106421794A (zh) * | 2016-09-27 | 2017-02-22 | 黑龙江珍宝岛药业股份有限公司 | 一种用于治疗ⅱ型糖尿病的药物组合物及其制备方法 |
MX2020002312A (es) * | 2017-09-29 | 2020-09-17 | Hanmi Pharm Ind Co Ltd | Farmaceutica combinada que comprende dapagliflozina l-prolina y metformina. |
KR102500835B1 (ko) * | 2017-10-24 | 2023-02-17 | 한미약품 주식회사 | 리나글립틴 및 메트포르민을 포함하는 복합제제 및 그의 제조방법 |
TR201721824A2 (tr) * | 2017-12-26 | 2019-07-22 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Li̇nagli̇pti̇n ve metformi̇n i̇çeren modi̇fi̇ye salim sağlayan kombi̇nasyon |
CN113116850B (zh) * | 2019-12-31 | 2024-03-19 | 广州玻思韬控释药业有限公司 | 胃滞留片 |
KR20230051096A (ko) * | 2021-10-08 | 2023-04-17 | (주)셀트리온 | 안정성이 개선된 당뇨병 치료용 약학 조성물 |
CN115715768A (zh) * | 2022-11-24 | 2023-02-28 | 浙江昂利泰制药有限公司 | 一种小型西格列汀-二甲双胍缓释片及其制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100705210B1 (ko) * | 2004-09-23 | 2007-04-06 | 주식회사 한독약품 | 경구투여를 위한 당뇨병 치료용 약제학적 복합제제 |
KR20140013436A (ko) * | 2012-07-24 | 2014-02-05 | 한미약품 주식회사 | 메트포르민 및 로수바스타틴을 포함하는 경구용 복합 제제 |
KR20140018832A (ko) * | 2010-07-09 | 2014-02-13 | 비에이치브이 파르마, 인크. | 레모글리플로진을 포함하는 짧은 반감기 약제용의 즉시/지연 조합 방출 전달 시스템 |
KR20140052970A (ko) * | 2011-03-07 | 2014-05-07 | 베링거 인겔하임 인터내셔날 게엠베하 | 메트포르민 및 dpp-4 억제제 또는 sglt-2 억제제를 포함하는 약제학적 조성물 |
KR101409330B1 (ko) * | 2012-05-11 | 2014-06-18 | 안국약품 주식회사 | 복용순응도가 향상된 서방성 당뇨병 치료용 복합제제 및 이의 제조방법 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100760430B1 (ko) * | 2004-12-31 | 2007-10-04 | 한미약품 주식회사 | 당뇨병 치료제의 경구 투여용 서방성 복합 제제 및 이의제조 방법 |
KR20130103631A (ko) * | 2005-06-03 | 2013-09-23 | 미쓰비시 타나베 파마 코퍼레이션 | 의약의 병용 및 그 용도 |
CA2633167A1 (en) * | 2005-12-16 | 2007-07-12 | Merck & Co., Inc. | Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with metformin |
CN101168059A (zh) * | 2007-10-12 | 2008-04-30 | 重庆医药工业研究院有限责任公司 | 一种含有双胍、磺酰脲和噻唑烷二酮的稳定的药物组合物及其制备方法 |
CN101168060B (zh) * | 2007-10-12 | 2012-06-13 | 重庆医药工业研究院有限责任公司 | 一种含双胍和磺酰脲的稳定的药物组合物及其制备方法 |
AU2009210641A1 (en) * | 2008-02-05 | 2009-08-13 | Merck Sharp & Dohme Corp. | Pharmaceutical compositions of a combination of metformin and a dipeptidyl peptidase-IV inhibitor |
CN117547538A (zh) * | 2009-02-13 | 2024-02-13 | 勃林格殷格翰国际有限公司 | 包含dpp-4抑制剂(利格列汀)任选地组合其它抗糖尿病药的抗糖尿病药物 |
US9555001B2 (en) * | 2012-03-07 | 2017-01-31 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition and uses thereof |
CN103285398B (zh) * | 2013-06-28 | 2015-07-22 | 青岛黄海制药有限责任公司 | 含有dpp-ⅳ抑制剂和第二种糖尿病药物的复方制剂及其制备方法 |
-
2014
- 2014-12-23 KR KR1020140186677A patent/KR101526825B1/ko active IP Right Grant
-
2015
- 2015-12-22 CN CN201580070627.7A patent/CN107205969B/zh active Active
- 2015-12-22 MY MYPI2017702340A patent/MY196438A/en unknown
- 2015-12-22 SG SG11201705194XA patent/SG11201705194XA/en unknown
- 2015-12-22 TW TW104143123A patent/TW201628602A/zh unknown
- 2015-12-22 WO PCT/KR2015/014096 patent/WO2016105084A2/ko active Application Filing
-
2017
- 2017-06-22 PH PH12017501184A patent/PH12017501184B1/en unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100705210B1 (ko) * | 2004-09-23 | 2007-04-06 | 주식회사 한독약품 | 경구투여를 위한 당뇨병 치료용 약제학적 복합제제 |
KR20140018832A (ko) * | 2010-07-09 | 2014-02-13 | 비에이치브이 파르마, 인크. | 레모글리플로진을 포함하는 짧은 반감기 약제용의 즉시/지연 조합 방출 전달 시스템 |
KR20140052970A (ko) * | 2011-03-07 | 2014-05-07 | 베링거 인겔하임 인터내셔날 게엠베하 | 메트포르민 및 dpp-4 억제제 또는 sglt-2 억제제를 포함하는 약제학적 조성물 |
KR101409330B1 (ko) * | 2012-05-11 | 2014-06-18 | 안국약품 주식회사 | 복용순응도가 향상된 서방성 당뇨병 치료용 복합제제 및 이의 제조방법 |
KR20140013436A (ko) * | 2012-07-24 | 2014-02-05 | 한미약품 주식회사 | 메트포르민 및 로수바스타틴을 포함하는 경구용 복합 제제 |
Also Published As
Publication number | Publication date |
---|---|
CN107205969A (zh) | 2017-09-26 |
MY196438A (en) | 2023-04-11 |
PH12017501184A1 (en) | 2017-12-18 |
TW201628602A (zh) | 2016-08-16 |
SG11201705194XA (en) | 2017-07-28 |
PH12017501184B1 (en) | 2017-12-18 |
KR101526825B1 (ko) | 2015-06-08 |
CN107205969B (zh) | 2020-06-30 |
WO2016105084A2 (ko) | 2016-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2016105084A3 (ko) | 당뇨병 치료용 약제학적 조성물 | |
HK1254756A1 (zh) | 作為組蛋白脫乙酰酶6抑制劑的1,3,4-噁二唑衍生物化合物及包含其的藥物組合物 | |
HK1251571A1 (zh) | 作為組蛋白脫乙酰基酶6抑制劑的1,3,4-噁二唑磺酰胺衍生化合物及含有其的醫藥組合物 | |
HK1251549A1 (zh) | 作為組蛋白去乙酰酶6抑制劑的1,3,4-噁二唑磺酰胺衍生物及含其的醫藥組合物 | |
GB201512314D0 (en) | Use of a composition containing 1,3-propanediol as an e-liquid | |
ZA201800015B (en) | Material for enhancing attributes of a topical or surface treatment composition | |
HK1256042A1 (zh) | 用於治療糖尿病周圍神經病變的hdac抑制劑 | |
MX2017000487A (es) | Procedimiento de secado. | |
PH12017501082A1 (en) | Calcium carbonate for plant protection | |
MX2018003707A (es) | Producto de superficie solida y su proceso de fabricacion. | |
WO2016080796A3 (ko) | 세스퀴테르펜 화합물을 포함하는, stat3 매개 질환의 예방 또는 치료용 약학적 조성물 및 이의 용도 | |
MX369661B (es) | Microcapsulas biocidas. | |
MX2021003830A (es) | Uso terapéutico del glucagón y combinación que incluye el mismo. | |
EP3235808A4 (en) | Modified taurine, and pharmaceutical composition for preventing or treating metabolic diseases containing same | |
WO2015149656A8 (zh) | 一类2,2'-串联双噻唑类化合物及其制备方法和用途 | |
EA201691465A1 (ru) | Средство для лечения сердечно-сосудистых заболеваний | |
EP3097918A4 (en) | Catecholamine production accelerator, and therapeutic and preventive agent and therapeutic and preventive food composition for diseases caused by catecholamine deficiency | |
EP3369419A4 (en) | Composition for treating diabetes | |
EP3366292A4 (en) | COMPOSITION FOR THE PREVENTION OR TREATMENT OF OBESITY CONTAINING ALPHA-LIPOIC ACID AND N-ACETYLCYSTEINE AS ACTIVE SUBSTANCES | |
WO2016038040A3 (en) | Dipeptidyl ketoamide compounds and their use for the treatment and/or prevention of fat accumulation | |
EP3165543A4 (en) | Diacrylate compound, composition thereof, and cured product thereof | |
EP3121167A4 (en) | Compound binding to pparg but not acting as promoter and pharmaceutical composition for treating pparg-related diseases containing same as active ingredient | |
EP3768274A4 (en) | COMPOSITION FOR USE IN THE TREATMENT OF CONDITIONS CAUSED BY CALCIUM DEFICIENCY | |
MX2019010723A (es) | Material adsorbente y de envasado. | |
MX2017016638A (es) | Compuestos organolepticos novedosos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 15873611 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12017501184 Country of ref document: PH |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 11201705194X Country of ref document: SG |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 15873611 Country of ref document: EP Kind code of ref document: A2 |